CrossRef Cited-by Linking Search Results

This Article:

has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking:

  • Release of monocyte migration signals by breast cancer cell lines after ablative and fractionated γ-irradiation
    Roman Hennel, Nikko Brix, Karin Seidl, Anne Ernst, Heike Scheithauer, Claus Belka, and Kirsten Lauber
    Radiation Oncology (2014) 9 :85
  • Prepubertal physical activity up-regulates estrogen receptor β, BRCA1 and p53 mRNA expression in the rat mammary gland
    M. Wang, B. Yu, K. Westerlind, R. Strange, G. Khan, D. Patil, K. Boeneman, and L. Hilakivi-Clarke
    Breast Cancer Research and Treatment (2009) 115 :213
  • Clofarabine, a novel adenosine analogue, reactivates DNA methylation-silenced tumour suppressor genes and inhibits cell growth in breast cancer cells
    Katarzyna Lubecka-Pietruszewska, Agnieszka Kaufman-Szymczyk, Barbara Stefanska, Barbara Cebula-Obrzut, Piotr Smolewski, and Krystyna Fabianowska-Majewska
    European Journal of Pharmacology (2014) 723 :276
  • Targeting the p53 Pathway
    Vita M. Golubovskaya and William G. Cance
    Surgical Oncology Clinics of North America (2013) 22 :747
  • ATR (ataxia telangiectasia mutated- and Rad3-related kinase) is activated by mild hypothermia in mammalian cells and subsequently activates p53
    Anne Roobol, Jo Roobol, Martin J. Carden, Amandine Bastide, Anne E. Willis, Warwick B. Dunn, Royston Goodacre, and C. Mark Smales
    Biochemical Journal (2011) 435 :499
  • Cadmium Modifies the Cell Cycle and Apoptotic Profiles of Human Breast Cancer Cells Treated with 5-Fluorouracil
    Yolande Asara, Juan Marchal, Esther Carrasco, Houria Boulaiz, Giuliana Solinas, Pasquale Bandiera, Maria Garcia, Cristiano Farace, Andrea Montella, and Roberto Madeddu
    International Journal of Molecular Sciences (2013) 14 :16600
  • Main signal pathways underlying the molecular mechanisms of the antitumor effects of wogonin
    Miao-Xin PENG, Hai-Wei ZHANG, and Bao-An CHEN
    Chinese Journal of Natural Medicines (2012) 10 :401
  • Assessing estrogen signaling aberrations in breast cancer risk using genetically engineered mouse models
    Priscilla A. Furth, M. Carla Cabrera, Edgar S. Díaz-Cruz, Sarah Millman, and Rebecca E. Nakles
    Annals of the New York Academy of Sciences (2011) 1229 :147
  • Simple Prediction Model of Axillary Lymph Node Positivity After Analyzing Molecular and Clinical Factors in Early Breast Cancer
    Mi Joo Chung, Jong Hoon Lee, Sung Hwan Kim, Young Jin Suh, and Hyun Joo Choi
    Medicine (2016) 95 :e3689
  • Targeting triple-negative breast cancer cells with 6,7-bis(hydroxymethyl)-1H,3H-pyrrolo[1,2-c]thiazoles
    Kathleen Santos, Mafalda Laranjo, Ana Margarida Abrantes, Ana F. Brito, Cristina Gonçalves, Ana Bela Sarmento Ribeiro, M. Filomena Botelho, Maria I.L. Soares, Andreia S.R. Oliveira, and Teresa M.V.D. Pinho e Melo
    European Journal of Medicinal Chemistry (2014) 79 :273
  • Essential role of PI3-kinase pathway in p53-mediated transcription: Implications in cancer chemotherapy
    R Suvasini and K Somasundaram
    Oncogene (2010) 29 :3605
  • p53 accumulation is a strong predictor of recurrence in estrogen receptor-positive breast cancer patients treated with aromatase inhibitors
    Mitsugu Yamamoto, Mitsuchika Hosoda, Kiichiroh Nakano, Shusheng Jia, Kanako C. Hatanaka, Emi Takakuwa, Yutaka Hatanaka, Yoshihiro Matsuno, and Hiroko Yamashita
    Cancer Science (2014) 105 :81
  • Disruption of estrogen receptor α-p53 interaction in breast tumors: a novel mechanism underlying the anti-tumor effect of radiation therapy
    Wensheng Liu, Margot M. Ip, Matthew B. Podgorsak, and Gokul M. Das
    Breast Cancer Research and Treatment (2009) 115 :43
  • RORα, a Potential Tumor Suppressor and Therapeutic Target of Breast Cancer
    Jun Du and Ren Xu
    International Journal of Molecular Sciences (2012) 13 :15755
  • Tumour Suppressive Effects of WEE1 Gene Silencing in Breast Cancer Cells
    Naghmeh Ghiasi, Mojtaba Habibagahi, Rozita Rosli, Abbas Ghaderi, Khatijah Yusoff, Ahmad Hosseini, Syahrilnizam Abdullah, and Mansooreh Jaberipour
    Asian Pacific Journal of Cancer Prevention (2013) 14 :6605
  • Glutamatergic stimulation triggers rapid Krüpple-like factor 4 expression in neurons and the overexpression of KLF4 sensitizes neurons to NMDA-induced caspase-3 activity
    Shanshan Zhu, Chao Tai, Brian A. MacVicar, William Jia, and Max S. Cynader
    Brain Research (2009) 1250 :49
  • p53: The Attractive Tumor Suppressor in the Cancer Research Field
    Toshinori Ozaki and Akira Nakagawara
    Journal of Biomedicine and Biotechnology (2011) 2011 :1
  • Associations between Polycyclic Aromatic Hydrocarbon–Related Exposures and p53 Mutations in Breast Tumors
    Irina Mordukhovich, Pavel Rossner, Mary Beth Terry, Regina Santella, Yu-Jing Zhang, Hanina Hibshoosh, Lorenzo Memeo, Mahesh Mansukhani, Chang-Min Long, Gail Garbowski, Meenakshi Agrawal, Mia M. Gaudet, Susan E. Steck, Sharon K. Sagiv, Sybil M. Eng, Susan L. Teitelbaum, Alfred I. Neugut, Kathleen Conway-Dorsey, and Marilie D. Gammon
    Environmental Health Perspectives (2009) 118 :511
  • Bioinformatics-based discovery and characterization of an AKT-selective inhibitor 9-chloro-2-methylellipticinium acetate (CMEP) in breast cancer cells
    Manchao Zhang, Xueliang Fang, Hongpeng Liu, Ribo Guo, Xiaojin Wu, Bihua Li, Feng Zhu, Yan Ling, Brian N. Griffith, Shaomeng Wang, and Dajun Yang
    Cancer Letters (2007) 252 :244
  • Cytochrome P450 1 family and cancers
    Ryeo-Eun Go, Kyung-A Hwang, and Kyung-Chul Choi
    The Journal of Steroid Biochemistry and Molecular Biology (2015) 147 :24
  • A benzimidazole derivative exhibiting antitumor activity blocks EGFR and HER2 activity and upregulates DR5 in breast cancer cells
    B Chu, F Liu, L Li, C Ding, K Chen, Q Sun, Z Shen, Y Tan, C Tan, and Y Jiang
    Cell Death and Disease (2015) 6 :e1686
  • Comparative Effects of Boric Acid and Calcium Fructoborate on Breast Cancer Cells
    R. Scorei, Raluca Ciubar, Cristina M. Ciofrangeanu, Valentina Mitran, Anisoara Cimpean, and Dana Iordachescu
    Biological Trace Element Research (2008) 122 :197
  • Association BetweenMGMTPromoter Hypermethylation and p53 Mutation in Glioblastoma
    Jamal Shamsara, Samaneh Sharif, Sima Afsharnezhad, Marzieh Lotfi, Hamid Reza Raziee, Kamran Ghaffarzadegan, Afshin Moradi, Saeed Rahighi, and Javad Behravan
    Cancer Investigation (2009) 27 :825
  • Camel urine components display anti-cancer properties in vitro
    Nujoud Al-Yousef, Ameera Gaafar, Basem Al-Otaibi, Ibrahim Al-Jammaz, Khaled Al-Hussein, and Abdelilah Aboussekhra
    Journal of Ethnopharmacology (2012) 143 :819
  • Silencing overexpression of FXYD3 protein in breast cancer cells amplifies effects of doxorubicin and γ-radiation on Na+/K+-ATPase and cell survival
    Chia-Chi Liu, Rachel Teh, Christine A. Mozar, Robert C. Baxter, and Helge H. Rasmussen
    Breast Cancer Research and Treatment (2016) 155 :203
  • Molecular mechanisms associated with breast cancer based on integrated gene expression profiling by bioinformatics analysis
    Di Wu, Bing Han, Liang Guo, and Zhimin Fan
    Journal of Obstetrics and Gynaecology (2016) 36 :615
  • ARTIK-52 induces replication-dependent DNA damage and p53 activation exclusively in cells of prostate and breast cancer origin
    Daria Fleyshman, Peter Cheney, Anda Ströse, Shaila Mudambi, Alfiya Safina, Mairead Commane, Andrei Purmal, Kelsey Morgan, Nicholas J. Wang, Joe Gray, Paul T. Spellman, Natalia Issaeva, and Katerina Gurova
    Cell Cycle (2016) 15 :455
  • Olive oil oleuropein has anti-breast cancer properties with higher efficiency on ER-negative cells
    Maha H. Elamin, Maha H. Daghestani, Sawsan A. Omer, Mai A Elobeid, Promy Virk, Ebtesam M. Al-Olayan, Zeinab K. Hassan, Osama B. Mohammed, and Abdelilah Aboussekhra
    Food and Chemical Toxicology (2013) 53 :310
  • Expression of the human tumor suppressor p53 induces cell death in Pichia pastoris
    Salma Abdelmoula-Souissi, Imed Mabrouk, Ali Gargouri, and Raja Mokdad-Gargouri
    FEMS Yeast Research (2012) 12 :2
  • Novel Insights into Combating Cancer Chemotherapy Resistance Using a Plasmonic Nanocarrier: Enhancing Drug Sensitiveness and Accumulation Simultaneously with Localized Mild Photothermal Stimulus of Femtosecond Pulsed Laser
    Liming Wang, Xiaoying Lin, Jing Wang, Zhijian Hu, Yinglu Ji, Shuai Hou, Yuliang Zhao, Xiaochun Wu, and Chunying Chen
    Advanced Functional Materials (2014) 24 :4229
  • A literature review of molecular markers predictive of clinical response to cytotoxic chemotherapy in patients with breast cancer
    Ikuo Sekine, Chikako Shimizu, Kazuto Nishio, Nagahiro Saijo, and Tomohide Tamura
    International Journal of Clinical Oncology (2009) 14 :112
  • TP53 Status and Response to Treatment in Breast Cancers
    Mariana Varna, Guilhem Bousquet, Louis-François Plassa, Philippe Bertheau, and Anne Janin
    Journal of Biomedicine and Biotechnology (2011) 2011 :1
  • Altered Expression of the PMAIP1 Gene: A Major Player in the Evolution of Gastrointestinal and Systemic Malignancies
    Shailendra Kapoor
    Digestive Diseases and Sciences (2008) 53 :2834
  • JNK pathway regulates estradiol-induced apoptosis in hormone-dependent human breast cancer cells
    Nedret Altiok, Meral Koyuturk, and Soner Altiok
    Breast Cancer Research and Treatment (2007) 105 :247
  • Alterations in p53, BRCA1, ATM, PIK3CA, and HER2 genes and their effect in modifying clinicopathological characteristics and overall survival of Bulgarian patients with breast cancer
    Stefan S. Bozhanov, Svetla G. Angelova, Maria E. Krasteva, Tsanko L. Markov, Svetlana L. Christova, Ivan G. Gavrilov, and Elena I. Georgieva
    Journal of Cancer Research and Clinical Oncology (2010) 136 :1657
  • UBE2Q1 in a Human Breast Carcinoma Cell Line: Overexpression and Interaction with p53
    Sayed Mohammad Shafiee, Mozhgan Rasti, Atefeh Seghatoleslam, Tayebeh Azimi, and Ali Akbar Owji
    Asian Pacific Journal of Cancer Prevention (2015) 16 :3723
  • Molecular classification of breast carcinomas with particular emphasis on “basal-like” carcinoma: A critical review
    Mohammad Ali Lavasani and Farid Moinfar
    Journal of Biophotonics (2012) 5 :345
  • Late onset Li-Fraumeni Syndrome with bilateral breast cancer and other malignancies: case report and review of the literature
    Karin Kast, Mechthild Krause, Markus Schuler, Katrin Friedrich, Barbara Thamm, Andrea Bier, Wolfgang Distler, and Stefan Krüger
    BMC Cancer (2012) 12 :
  • MYBBP1A suppresses breast cancer tumorigenesis by enhancing the p53 dependent anoikis
    Kensuke Akaogi, Wakana Ono, Yuki Hayashi, Hiroyuki Kishimoto, and Junn Yanagisawa
    BMC Cancer (2013) 13 :
  • Association between polymorphisms of XRCC1, p53 and MDR1 genes, the expression of their protein products and prognostic significance in human breast cancer.
    Silvia Rybarova, Janka Vecanova, Ingrid Hodorova, Jozef Mihalik, Martina Cizmarikova, Ján Mojzis, Peter Solar, Marián Benicky, Marian Adamkov, and Ladislav Mirossay
    Medical Science Monitor (2011) 17 :BR354
  • PAC, a novel curcumin analogue, has anti-breast cancer properties with higher efficiency on ER-negative cells
    Ensaf M. Al-Hujaily, Ameera Gaafar Mohamed, Ibtehaj Al-Sharif, Khairia M. Youssef, Pulicat S. Manogaran, Basem Al-Otaibi, Amal Al-Haza’a, Ibrahim Al-Jammaz, Khaled Al-Hussein, and Abdelilah Aboussekhra
    Breast Cancer Research and Treatment (2011) 128 :97
  • Eugenol triggers apoptosis in breast cancer cells through E2F1/survivin down-regulation
    Ibtehaj Al-Sharif, Adnane Remmal, and Abdelilah Aboussekhra
    BMC Cancer (2013) 13 :
  • Distinct Rayleigh Scattering from Hot Spot Mutant p53 Proteins Reveals Cancer Cells
    Ho Joon Jun, Anh H. Nguyen, Yeul Hong Kim, Kyong Hwa Park, Doyoun Kim, Kyeong Kyu Kim, and Sang Jun Sim
    Small (2014) 10 :2954
  • Analysis of centromere signal patterns in breast cancer cells with chromosomal instability using image cytometry combined with centromere fluorescence in situ hybridization
    Hideaki Ito, Atsunori Oga, Kenzo Ikemoto, Tomoko Furuya, Noriko Maeda, Shigeru Yamamoto, Shigeto Kawauchi, Hiroshi Itoh, Masaaki Oka, and Kohsuke Sasaki
    Cytometry Part A (2014) 85 :809
  • Simvastatin induces apoptosis in human breast cancer cells: p53 and estrogen receptor independent pathway requiring signalling through JNK
    Meral Koyuturk, Melike Ersoz, and Nedret Altiok
    Cancer Letters (2007) 250 :220
  • Cytotoxic Activity of Piper cubeba Extract in Breast Cancer Cell Lines
    Potchanapond Graidist, Mananya Martla, and Yaowapa Sukpondma
    Nutrients (2015) 7 :2707
  • Transcription factor p53 exhibits increased binding to the α2-macroglobulin gene promoter and decreased glycosylation in fetal and adult rat liver during the acute-phase response
    Mirjana Mihailovic, G. Poznanovic, Svetlana Dinic, Nevena Grdovic, Melita Vidakovic, Vesna Martinovic, and Desanka Bogojevic
    Archives of Biological Sciences (2008) 60 :347
  • p53 Modulates Notch Signaling in MCF-7 Breast Cancer Cells by Associating With the Notch Transcriptional Complex Via MAML1
    Jieun Yun, Ingrid Espinoza, Antonio Pannuti, Damian Romero, Luis Martinez, Mary Caskey, Adina Stanculescu, Maurizio Bocchetta, Paola Rizzo, Vimla Band, Hamid Band, Hwan Mook Kim, Song-Kyu Park, Keon Wook Kang, Maria Laura Avantaggiati, Christian R. Gomez, Todd Golde, Barbara Osborne, and Lucio Miele
    Journal of Cellular Physiology (2015) 230 :3115
  • Evaluation of HER2 and p53 expression in predicting response to docetaxel-based first-line chemotherapy in advanced breast cancer
    Andrea Camerini, Sara Donati, Paolo Viacava, Olimpia Siclari, Cheti Puccetti, Gianna Tartarelli, Chiara Valsuani, Filomena De Luca, Leonardo Martini, Andrea Cavazzana, and Domenico Amoroso
    Journal of Experimental & Clinical Cancer Research (2011) 30 :38
  • Expression of SPRR3 is associated with tumor cell proliferation in less advanced stages of breast cancer
    Jin Cheon Kim, Jong Han Yu, Yoon Kyung Cho, Choon Sik Jung, Sei Hyun Ahn, Gyungyub Gong, Yong Sung Kim, and Dong-Hyung Cho
    Breast Cancer Research and Treatment (2012) 133 :909
  • Additive enhancement of apoptosis by TRAIL and fenretinide in metastatic breast cancer cells in vitro
    Engin Ulukaya, Mehmet Sarimahmut, Buse Cevatemre, Ferda Ari, Azmi Yerlikaya, and Konstantinos Dimas
    Biomedicine & Pharmacotherapy (2014) 68 :477
  • Clickable Protein Nanocapsules for Targeted Delivery of Recombinant p53 Protein
    Muxun Zhao, Yarong Liu, Renee S. Hsieh, Nova Wang, Wanyi Tai, Kye-Il Joo, Pin Wang, Zhen Gu, and Yi Tang
    Journal of the American Chemical Society (2014) 136 :15319
  • Targeting mutant p53 protein and the tumor vasculature: an effective combination therapy for advanced breast tumors
    Yayun Liang, Cynthia Besch-Williford, Indira Benakanakere, Philip E. Thorpe, and Salman M. Hyder
    Breast Cancer Research and Treatment (2011) 125 :407
  • New insight on the biological role of p53 protein as a tumor suppressor: re-evaluation of its clinical significance in triple-negative breast cancer
    Min-Sun Jin, In Ae Park, Ji Young Kim, Yul Ri Chung, Seock-Ah Im, Kyung-Hun Lee, Hyeong-Gon Moon, Wonshik Han, Dong-Young Noh, and Han Suk Ryu
    Tumor Biology (2016) 37 :11017
  • Ziyuglycoside II Inhibits the Growth of Human Breast Carcinoma MDA-MB-435 Cells via Cell Cycle Arrest and Induction of Apoptosis through the Mitochondria Dependent Pathway
    Xue Zhu, Ke Wang, Kai Zhang, Biao Huang, Jue Zhang, Yi Zhang, Lan Zhu, Bin Zhou, and Fanfan Zhou
    International Journal of Molecular Sciences (2013) 14 :18041
  • Contribution of mammalian selenocysteine-containing proteins to carcinogenesis
    Elena Gennadyevna Varlamova and Irina Valentinovna Cheremushkina
    Journal of Trace Elements in Medicine and Biology (2017) 39 :76
  • Single cell resolution in vivo imaging of DNA damage following PARP inhibition
    Katherine S. Yang, Rainer H. Kohler, Matthieu Landon, Randy Giedt, and Ralph Weissleder
    Scientific Reports (2015) 5 :10129
  • Isoform specific phosphorylation of p53 by protein kinase CK1
    Andrea Venerando, Oriano Marin, Giorgio Cozza, Victor H. Bustos, Stefania Sarno, and Lorenzo Alberto Pinna
    Cellular and Molecular Life Sciences (2010) 67 :1105
  • Mutations in p53, p53 protein overexpression and breast cancer survival
    Pavel Rossner Jr, Marilie D. Gammon, Yu-Jing Zhang, Mary Beth Terry, Hanina Hibshoosh, Lorenzo Memeo, Mahesh Mansukhani, Chang-Min Long, Gail Garbowski, Meenakshi Agrawal, Tara S. Kalra, Mia M. Gaudet, Susan L. Teitelbaum, Alfred I. Neugut, and Regina M. Santella
    Journal of Cellular and Molecular Medicine (2009) 13 :3847
  • The inference of breast cancer metastasis through gene regulatory networks
    F.K. Ahmad, S. Deris, and N.H. Othman
    Journal of Biomedical Informatics (2012) 45 :350
  • Interaction of a standardized mistletoe (Viscum album) preparation with antitumor effects of Trastuzumab in vitro
    U. Weissenstein, M. Kunz, K. Urech, U. Regueiro, and S. Baumgartner
    BMC Complementary and Alternative Medicine (2016) 16 :
  • Targeted Expression of miR-34a Using the T-VISA System Suppresses Breast Cancer Cell Growth and Invasion
    Laisheng Li, Xinhua Xie, Jinmei Luo, Min Liu, Shaoyan Xi, Jiaoli Guo, Yanan Kong, Minqing Wu, Jie Gao, Zeming Xie, Jun Tang, Xi Wang, Weidong Wei, Mingtian Yang, Mien-Chie Hung, and Xiaoming Xie
    Molecular Therapy (2012) 20 :2326
  • Cytotoxic Effects of Ellagitannins Isolated from Walnuts in Human Cancer Cells
    Vy Le, Debora Esposito, Mary H. Grace, Danny Ha, Anh Pham, Anthony Bortolazzo, Zackery Bevens, John Kim, Roy Okuda, Slavko Komarnytsky, Mary Ann Lila, and Joseph Brandon White
    Nutrition and Cancer (2014) 66 :1304
  • Systematic analysis of the p53‑related microRNAs in breast cancer revealing their essential roles in the cell cycle
    Enxiang Zhou, Na Hui, Min Shu, Baiping Wu, and Jianlin Zhou
    Oncology Letters (2015) :
  • Rapamycin sensitizes Akt inhibition in malignant human breast epithelial cells
    Jie Zheng, Alice Hudder, Kim Zukowski, and Raymond F. Novak
    Cancer Letters (2010) 296 :74
  • p53 Expression in MCF7, T47D and MDA-MB 468 Breast Cancer Cell Lines Treated with Adriamycin Using RT-PCR and Immunocytochemistry
    S. Kaabinejadian ., Sh. Fouladdel ., M. Ramezani ., and E. Azizi .
    Journal of Biological Sciences (2008) 8 :380
  • Effect of p53 codon 72 genotype on breast cancer survival depends on p53 gene status
    Ye Xu, Lihua Yao, Ailian Zhao, Tao Ouyang, Jinfeng Li, Tianfeng Wang, Zhaoqing Fan, Tie Fan, Benyao Lin, Youyong Lu, and Yuntao Xie
    International Journal of Cancer (2008) 122 :2761
  • p53siRNA therapy reduces cell proliferation, migration and induces apoptosis in triple negative breast cancer cells
    Cornelia Braicu, Valentina Pileczki, Alexandru Irimie, and Ioana Berindan-Neagoe
    Molecular and Cellular Biochemistry (2013) 381 :61
  • Targeting Chk1 in p53-deficient triple-negative breast cancer is therapeutically beneficial in human-in-mouse tumor models
    Cynthia X. Ma, Shirong Cai, Shunqiang Li, Christine E. Ryan, Zhanfang Guo, W. Timothy Schaiff, Li Lin, Jeremy Hoog, Reece J. Goiffon, Aleix Prat, Rebecca L. Aft, Matthew J. Ellis, and Helen Piwnica-Worms
    Journal of Clinical Investigation (2012) 122 :1541
  • A simple immunohistochemical panel comprising 2 conventional markers, Ki67 and p53, is a powerful tool for predicting patient outcome in luminal-type breast cancer
    Takayuki Kobayashi, Keiichi Iwaya, Tomoyuki Moriya, Tamio Yamasaki, Hitoshi Tsuda, Junji Yamamoto, and Osamu Matsubara
    BMC Clinical Pathology (2013) 13 :
  • p53 expression and relationship with MDM2 amplification in breast carcinomas
    Nur Buyukpinarbasili, Zuhal Gucin, Yeliz Emine Ersoy, Ayca İlbak, Huseyin Kadioglu, and Mahmut Muslumanoglu
    Annals of Diagnostic Pathology (2016) 21 :29
  • Inhibition of tumor angiogenesis and growth by nanoparticle-mediated p53 gene therapy in mice
    S Prabha, B Sharma, and V Labhasetwar
    Cancer Gene Therapy (2012) 19 :530
  • Breast Cancer Stem Cells and Tumor Suppressor Genes
    Wendy W. Hwang-Verslues, King-Jen Chang, Eva Y.-H.P. Lee, and Wen-Hwa Lee
    Journal of the Formosan Medical Association (2008) 107 :751
  • Cytochrome P450 2E1 (CYP2E1) regulates the response to oxidative stress and migration of breast cancer cells
    Travis Leung, Ramkumar Rajendran, Subir Singh, Richa Garva, Marija Krstic-Demonacos, and Constantinos Demonacos
    Breast Cancer Research (2013) 15 :R107
  • Coexistent Loss of the Expressions of BRCA1 and p53 Predicts Poor Prognosis in Triple-Negative Breast Cancer
    Min Chong Kim, Jung Eun Choi, Soo Jung Lee, and Young Kyung Bae
    Annals of Surgical Oncology (2016) 23 :3524
  • Estrogen Receptor-beta Mediates the Protective Effects of Aromatase Induction in the MMTV-Her-2/neu x Aromatase Double Transgenic Mice
    Hareesh B. Nair, Rao P. Perla, Nameer B. Kirma, Naveen K. Krishnegowda, Manonmani Ganapathy, Rajib Rajhans, Sujit S. Nair, Pothana Saikumar, Ratna K. Vadlamudi, and Rajeshwar Rao Tekmal
    Hormones and Cancer (2012) 3 :26
  • p53-dependent expression of CXCR5 chemokine receptor in MCF-7 breast cancer cells
    Nikita A. Mitkin, Christina D. Hook, Anton M. Schwartz, Subir Biswas, Dmitry V. Kochetkov, Alisa M. Muratova, Marina A. Afanasyeva, Julia E. Kravchenko, Arindam Bhattacharyya, and Dmitry V. Kuprash
    Scientific Reports (2015) 5 :9330
  • NOLC1, an Enhancer of Nasopharyngeal Carcinoma Progression, Is Essential for TP53 to Regulate MDM2 Expression
    Yu-Chyi Hwang, Tung-Ying Lu, Dah-Yeou Huang, Yuan-Sung Kuo, Cheng-Fu Kao, Ning-Hsing Yeh, Han-Chung Wu, and Chin-Tarng Lin
    The American Journal of Pathology (2009) 175 :342
  • 2,3,6- Tribromo- 4,5- dihydroxybenzyl Methyl Ether Induces Growth inhibition and apoptosis in MCF-7 human breast cancer cells
    Ji-Hyeon Lee, Sang Eun Park, Mohammad Akbar Hossain, Min Young Kim, Mi-Na Kim, Hae Young Chung, Jae Sue Choi, Young Hyun Yoo, and Nam Deuk Kim
    Archives of Pharmacal Research (2007) 30 :1132
  • c-Myc Attenuates The Ability of Doxorubicin to Reduce The Colony Formation Partially Through Regulating Nbs1 in U2OS Cells*
    Han-Qing SHI, Hui HUANG, Xi-Tao ZHANG, Jian-Chao ZHANG, Xiu-Tan LUO, Xiu-E PENG, Bai-Qu HUANG, and Jun LU
  • Expression of p53 Breast Cancer in Kurdish Women in the West of Iran: a Reverse Correlation with Lymph Node Metastasis
    Mehrdad Payandeh, Masoud Sadeghi, Edris Sadeghi, and Seyed-Hamid Madani
    Asian Pacific Journal of Cancer Prevention (2016) 17 :1261
  • Cytotoxic Effects of Intranasal Midazolam on Nasal Mucosal Tissue
    I Ozbay, C Kucur, A Değer, I Ital, Cayci M Kasim, and F Oghan
    Journal of Craniofacial Surgery (2015) 26 :2008
  • Down-regulation of estrogen receptor-alpha and rearranged during transfection tyrosine kinase is associated with withaferin a-induced apoptosis in MCF-7 breast cancer cells
    Xuan Zhang, Ridhwi Mukerji, Abbas K Samadi, and Mark S Cohen
    BMC Complementary and Alternative Medicine (2011) 11 :
  • PLA2R1 kills cancer cells by inducing mitochondrial stress
    Arnaud Augert, David Vindrieux, Christophe A. Girard, Benjamin Le Calvé, Baptiste Gras, Mylène Ferrand, Benjamin P. Bouchet, Alain Puisieux, Yvan de Launoit, Hélène Simonnet, Gérard Lambeau, and David Bernard
    Free Radical Biology and Medicine (2013) 65 :969
  • The immune system and inflammation in breast cancer
    Xinguo Jiang and David J. Shapiro
    Molecular and Cellular Endocrinology (2014) 382 :673
  • Increased sensitivity of BRCA defective triple negative breast tumors to plumbagin through induction of DNA Double Strand Breaks (DSB)
    Rakesh Sathish Nair, Jerald Mahesh Kumar, Jedy Jose, Veena Somasundaram, Sreelatha K. Hemalatha, Satheesh Kumar Sengodan, Revathy Nadhan, Thapasimuthu V. Anilkumar, and Priya Srinivas
    Scientific Reports (2016) 6 :26631
  • Oncogenic HoxB7 requires TALE cofactors and is inactivated by a dominant-negative Pbx1 mutant in a cell-specific manner
    Luis C. Fernandez, M.C. Errico, L. Bottero, D. Penkov, M. Resnati, F. Blasi, and A. Caré
    Cancer Letters (2008) 266 :144
  • Association of loss of BRCA1 expression with centrosome aberration in human breast cancer
    Atsushi Shimomura, Yasuo Miyoshi, Tetsuya Taguchi, Yasuhiro Tamaki, and Shinzaburo Noguchi
    Journal of Cancer Research and Clinical Oncology (2009) 135 :421
  • Comparison of DGGE and immunohistochemistry in the detection of TP53 variants in a Brazilian sample of sporadic breast tumors
    Vitor Rezende da Costa Aguiar, Melissa de Freitas Cordeiro-Silva, Alex Assis de Carvalho, and Iúri Drumond Louro
    Molecular Biology Reports (2011) 38 :3351
  • A Chimeric p53 Evades Mutant p53 Transdominant Inhibition in Cancer Cells
    Abood Okal, Mohanad Mossalam, Karina J. Matissek, Andrew S. Dixon, Philip J. Moos, and Carol S. Lim
    Molecular Pharmaceutics (2013) 10 :3922
  • Interactions Between Ataxia Telangiectasia Mutated Kinase Inhibition, Poly(ADP-ribose) Polymerase-1 Inhibition and BRCA1 Status in Breast Cancer Cells
    Jozefa Węsierska-Gądek and Sarah Heinzl
    Journal of Cancer Prevention (2014) 19 :125
  • Abrogation of p53 by its antisense in MCF-7 breast carcinoma cells increases cyclin D1 via activation of Akt and promotion of cell proliferation
    Rishi Raj Chhipa, Ratna Kumari, Ankur Kumar Upadhyay, and Manoj Kumar Bhat
    Experimental Cell Research (2007) 313 :3945
  • 5,7,4⿲-Trihydroxy-6,8-diprenylisoflavone and lupalbigenin, active components of Derris scandens, induce cell death on breast cancer cell lines
    Aman Tedasen, Suchada Sukrong, Boonchoo Sritularak, Theera Srisawat, and Potchanapond Graidist
    Biomedicine & Pharmacotherapy (2016) 81 :235
  • Integrative network-based approach identifies key genetic elements in breast invasive carcinoma
    Mohamed Hamed, Christian Spaniol, Alexander Zapp, and Volkhard Helms
    BMC Genomics (2015) 16 :S2
  • In vitro evaluation of oestrogenic/androgenic activity of the serum organochlorine pesticide mixtures previously described in a breast cancer case–control study
    Javier Rivero, Octavio P. Luzardo, Luis A. Henríquez-Hernández, Rubén P. Machín, José Pestano, Manuel Zumbado, Luis D. Boada, María Camacho, and Pilar F. Valerón
    Science of The Total Environment (2015) 537 :197
  • Dual Functional Graphene Derivative-Based Electrochemical Platforms for Detection of theTP53Gene with Single Nucleotide Polymorphism Selectivity in Biological Samples
    Berta Esteban-Fernández de Ávila, Elena Araque, Susana Campuzano, María Pedrero, Berna Dalkiran, Rodrigo Barderas, Reynaldo Villalonga, Esma Kiliç, and José M. Pingarrón
    Analytical Chemistry (2015) 87 :2290
  • Large-scale RNA-Seq Transcriptome Analysis of 4043 Cancers and 548 Normal Tissue Controls across 12 TCGA Cancer Types
    Li Peng, Xiu Wu Bian, Di Kang Li, Chuan Xu, Guang Ming Wang, Qing You Xia, and Qing Xiong
    Scientific Reports (2015) 5 :13413
  • Heat-shock transcription factor HSF1 has a critical role in human epidermal growth factor receptor-2-induced cellular transformation and tumorigenesis
    L Meng, V L Gabai, and M Y Sherman
    Oncogene (2010) 29 :5204
  • Systemic Delivery of an Oncolytic Adenovirus Expressing Soluble Transforming Growth Factor-βReceptor II–Fc Fusion Protein Can Inhibit Breast Cancer Bone Metastasis in a Mouse Model
    Zebin Hu, Zhenwei Zhang, Theresa Guise, and Prem Seth
    Human Gene Therapy (2010) 21 :1623
  • A review of the ethnic differences in breast cancer
    RL Bowen, J Stebbing, and LJ Jones
    Pharmacogenomics (2006) 7 :935
  • Estrogens decrease γ-ray–induced senescence and maintain cell cycle progression in breast cancer cells independently of p53
    Robert-Alain Toillon, Nicolas Magné, Ioanna Laïos, Pierre Castadot, Eric Kinnaert, Paul Van Houtte, Christine Desmedt, Guy Leclercq, and Marc Lacroix
    International Journal of Radiation Oncology*Biology*Physics (2007) 67 :1187
  • Heteroatom-Substituted Analogues of Orphan Nuclear Receptor Small Heterodimer Partner Ligand and Apoptosis Inducer (E)-4-[3-(1-Adamantyl)-4-hydroxyphenyl]-3-chlorocinnamic Acid
    Zebin Xia, Lulu Farhana, Ricardo G. Correa, Jayanta K. Das, David J. Castro, Jinghua Yu, Robert G. Oshima, John C. Reed, Joseph A. Fontana, and Marcia I. Dawson
    Journal of Medicinal Chemistry (2011) 54 :3793
  • Role of p53 in Cell Death and Human Cancers
    Toshinori Ozaki and Akira Nakagawara
    Cancers (2011) 3 :994
  • Antiosteoporotic Effects of Huangqi Sanxian Decoction in Cultured Rat Osteoblasts by Proteomic Characterization of the Target and Mechanism
    Chong-Chong Guo, Li-Hua Zheng, Jian-Ying Fu, Jian-Hong Zhu, Yan-Xing Zhou, Tao Zeng, and Zhi-Kun Zhou
    Evidence-Based Complementary and Alternative Medicine (2015) 2015 :1
  • Characterization of the biological activity of a potent small molecule Hec1 inhibitor TAI-1
    Lynn YL Huang, Ying-Shuan Lee, Jiann-Jyh Huang, Chia-chi Chang, Jia-Ming Chang, Shih-Hsien Chuang, Kuo-Jang Kao, Yung-Jen Tsai, Pei-Yi Tsai, Chia-Wei Liu, Her-Sheng Lin, and Johnson YN Lau
    Journal of Experimental & Clinical Cancer Research (2014) 33 :6
  • Cell cycle kinetics, apoptosis rates and gene expressions ofMDR-1,TP53,BCL-2andBAXin transmissible venereal tumour cells and their association with therapy response
    M. M. Flórez, H. B. Fêo, G. N. da Silva, R. S. Yamatogi, A. J. Aguiar, J. P. Araújo, and N. S. Rocha
    Veterinary and Comparative Oncology (2016) :n/a
  • The biological, clinical and prognostic implications of p53 transcriptional pathways in breast cancers
    Tarek M Abdel-Fatah, Desmond G Powe, Johnson Agboola, Martyna Adamowicz-Brice, Roger W Blamey, Maria A Lopez-Garcia, Andrew R Green, Jorge S Reis-Filho, and Ian O Ellis
    The Journal of Pathology (2009) :n/a
  • The impact of p53 in predicting clinical outcome of breast cancer patients with visceral metastasis
    P. Yang, C. W. Du, M. Kwan, S. X. Liang, and G. J. Zhang
    Scientific Reports (2013) 3 :
  • p53 Protein Accumulation and Presence of Visceral Metastasis Are Independent Prognostic Factors for Survival in Patients with Metastatic Inflammatory Breast Carcinoma
    Canfeza Sezgin, Erhan Gokmen, Murat Kapkac, Osman Zekioglu, Mustafa Esassolak, Bulent Karabulut, Ulus Ali Sanli, and Ruchan Uslu
    Medical Principles and Practice (2011) 20 :159
  • HER-2 Positive and p53 Negative Breast Cancers are Associated With Poor Prognosis
    Dhafir Al-azawi, Sum Leong, Limy Wong, Elaine Kay, Arnold D. K. Hill, and Leonie Young
    Cancer Investigation (2011) 29 :365
  • Asymmetric segregation of template DNA strands in basal-like human breast cancer cell lines
    Wenyu Liu, Gajan Jeganathan, Sohrab Amiri, Katherine M Morgan, Bríd M Ryan, and Sharon R Pine
    Molecular Cancer (2013) 12 :139
  • Fluorescence-based recombination assay for sensitive and specific detection of genotoxic carcinogens in human cells
    Ivanildce C. Ireno, Cindy Baumann, Regina Stöber, Jan G. Hengstler, and Lisa Wiesmüller
    Archives of Toxicology (2014) 88 :1141
  • DNA double-strand break repair activities in mammary epithelial cells--influence of endogenous p53 variants
    M. Keimling and L. Wiesmuller
    Carcinogenesis (2009) 30 :1260
  • Clinical response to primary letrozole therapy in elderly patients with early breast cancer: Possible role for p53 as a biomarker
    Veerabhadram Garimella, Tasadooq Hussain, Vijay Agarwal, Selvi Radhakrishna, John N. Fox, Peter J. Kneeshaw, Ervine D. Long, Tapan K. Mahapatra, Penelope L. McManus, Michael J. Lind, Philip J. Drew, and Lynn Cawkwell
    International Journal of Surgery (2014) 12 :821
  • Intratumoral T cells, tumor-associated macrophages, and regulatory T cells: Association with p53 mutations, circulating tumor DNA and survival in women with ovarian cancer
    Chirag A. Shah, Kimberly H. Allison, Rochelle L. Garcia, Heidi J. Gray, Barbara A. Goff, and Elizabeth M. Swisher
    Gynecologic Oncology (2008) 109 :215
  • Breast Carcinoma: The glucocorticoid receptor signalling in breast cancer
    Paraskevi Moutsatsou and Athanasios G. Papavassiliou
    Journal of Cellular and Molecular Medicine (2007) 12 :145